Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy

A Biological Profile of a Nonsteroidal Antiandrogen, SCH 13521 (4'–Nitro–3'–Trifluoromethylisobutyranilide)1

1972 • 328 citations

The Treatment of Benign Prostatic Hypertrophy with Flutamide (SCH 13521): A Placebo-Controlled Study

1975 • 116 citations

Sch 13521 In The Treatment Of Advanced Carcinoma Of The Prostate

1974 • 90 citations

Comparison of flutamide (SCH-13521) and diethylstilbestrol in untreated advanced prostatic cancer

1976 • 79 citations

The Effect of Flutamide on Testosterone Metabolism and the Plasma Levels of Androgens and Gonadotropins

1977 • 75 citations

Experience with Flutamide in Previously Untreated Patients With Advanced Prostatic Cancer

1979 • 72 citations

Prostatic Cancer and Sch-13521: II. Histological Alterations and the Pituitary Gonadal Axis

1975 • 62 citations

Advanced prostatic carcinoma Flutamide therapy after conventional endocrine treatment

1975 • 56 citations

Effect of Flutamide on Cortisol Metabolism*

1978 • 26 citations